Biomarkers of ADHD Treatment Response

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 17, 2023

Primary Completion Date

March 30, 2024

Study Completion Date

March 30, 2024

Conditions
ADHD
Interventions
DRUG

Concerta

3-week trial of oral methylphenidate extended release

DRUG

Adderall-XR

3-week trial of oral mixed amphetamine salts, extended release, administered only to children who do not show at least 30% improvement during the Concerta/Methylphenidate trial.

Trial Locations (1)

02445

2 Brookline Place, Brookline

All Listed Sponsors
lead

Boston Children's Hospital

OTHER